the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 
Market Research Report

Wound Treatments in Japan

Published by Euromonitor International Contact us : +1-860-674-8796
Published 2009/05 Content info Pages: 42
Product code 91871
Price From  US $ 900 Order/Price list
US $ 900 PDF by E-mail (Single User License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Table of Contents

Wound Treatments in Japan
Euromonitor International
May 2009
List of Contents and Tables
Executive Summary
Maturity Produces Slow Growth
Government Encourages Self-medication
Domestic Companies Dominate
Distribution Remains Restricted
Shrinking Sales Over the Forecast Period
Key Trends and Developments
Demographic Changes Shape Consumer Demand
Government Focuses on Reducing Medical Costs
Men' s Health
Strong Players Face Challenges Through Mergers
Distribution on the Brink of Expansion
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
Market Data
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2008
Definitions
Summary 2 Research Sources
Daiichi Sankyo Co Ltd
Strategic Direction
Key Facts
Summary 3 Daichi Sankyo Co Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 4 DaiichiSankyo Group: Competitive Position 2008
Eisai Co Ltd
Strategic Direction
Key Facts
Summary 5 Eisai Co Ltd: Key Facts
Summary 6 Eisai Co Ltd: Operational Indicators
Production
Competitive Positioning
Summary 7 Eisai Co Ltd: Competitive Position 2008
Hisamitsu Pharmaceutical Co Inc
Strategic Direction
Key Facts
Summary 8 Hisamitsu Pharmaceutical Co Inc: Key Facts
Summary 9 Hisamitsu Pharmaceutical Co Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 10 Hisamitsu Pharmaceutical Co Inc: Competitive Position 2008
Lion Corp
Strategic Direction
Key Facts
Summary 11 Lion Corp: Key Facts
Summary 12 Lion Corp: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 13 Lion Corp: Competitive Position 2008
Miki Corp
Strategic Direction
Key Facts
Summary 14 Miki Corp: Key Facts
Company Background
Production
Summary 15 Miki Corp: Production Statistics 2008
Competitive Positioning
Summary 16 Miki Corp: Competitive Position 2008
Rohto Pharmaceutical Co Ltd
Strategic Direction
Key Facts
Summary 17 Rohto Pharmaceutical Co Ltd: Key Facts
Summary 18 Rohto Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 19 Rohto Pharmaceutical Co Ltd: Competitive Position 2008
Sahto Pharmaceutical Co Ltd
Strategic Direction
Key Facts
Summary 20 Sato Pharmaceutical Co Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 21 Sato Pharmaceutical Co Ltd: Competitive Position 2008
Ssp Co Ltd
Strategic Direction
Key Facts
Summary 22 SSP Co Ltd: Key Facts
Summary 23 SSP Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 24 SSP Co Ltd: Competitive Position 2008
Taisho Pharmaceutical Co Ltd
Strategic Direction
Key Facts
Summary 25 Taisho Pharmaceutical Co Ltd: Key Facts
Summary 26 Taisho Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 27 Taisho Pharmaceutical Co Ltd: Competitive Position 2008
Takeda Chemical Industries Ltd
Strategic Direction
Key Facts
Summary 28 Takeda Chemical Industries Ltd: Key Facts
Summary 29 Takeda Chemical Industries Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 30 Takeda Chemical Industries Ltd: Competitive Position 2008
Sector Data
Table 12 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 13 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 14 Wound Treatments Company Shares by Value 2004-2008
Table 15 Wound Treatments Brand Shares by Value 2005-2008
Table 16 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 17 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013

Related Report
Back to Top
Please inform me when related publications are released
InfoWatch